(Q44893876)

7 December 2017

title

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis (English)

1 reference

7 December 2017

0 references

Bal dit Sollier C

1

1 reference

7 December 2017

Kang C

2

1 reference

7 December 2017

Berge N

3

1 reference

7 December 2017

Herault JP

4

1 reference

7 December 2017

Bonneau M

5

1 reference

7 December 2017

Herbert JM

6

1 reference

7 December 2017

Drouet L

7

1 reference

7 December 2017

publication date

1 June 2004

1 reference

Journal of Thrombosis and Haemostasis

7 December 2017

published in

1 reference

7 December 2017

volume

2

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

925-930

1 reference

Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Heparin-induced thrombocytopenia: a ten-year retrospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif--the C-domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Are the pharmacokinetic parameters of low molecular weight heparins predictive of their clinical efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

Synthesis of thrombin-inhibiting heparin mimetics without side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00719.X

10.1111/J.1538-7836.2004.00719.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference